Report of meeting on the development of influenza va... [Vaccine. 2005] - PubMed

Save items

loading

Related citations in PubMed

Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007. [Vaccine. 2008]
Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007.
Girard MP, Osterhaus A, Pervikov Y, Palkonyay L, Kieny MP. Vaccine. 2008 May 12; 26(20):2443-50. Epub 2008 Mar 28.
Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005. [Vaccine. 2006]
Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005.
Hampson AW, Osterhaus AD, Pervikov Y, Kieny MP. Vaccine. 2006 Jun 5; 24(23):4897-4900.
Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009. [Vaccine. 2009]
Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009.
Hayden FG, Howard WA, Palkonyay L, Kieny MP. Vaccine. 2009 Jun 24; 27(31):4079-89. Epub 2009 May 9.
Review Influenza vaccines: new developments. [Curr Opin Pharmacol. 2001]
Review Influenza vaccines: new developments.
Rimmelzwaan GF, Osterhaust AD. Curr Opin Pharmacol. 2001 Oct; 1(5):491-6.
Review The Vaccine Formulation Laboratory: a platform for access to adjuvants. [Vaccine. 2011]
Review The Vaccine Formulation Laboratory: a platform for access to adjuvants.
Collin N, Dubois PM. Vaccine. 2011 Jul 1; 29 Suppl 1:A37-9.

See reviews... See all...

Cited by 2 PubMed Central articles

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. [PLoS One. 2009]
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.
Bodewes R, Kreijtz JH, Baas C, Geelhoed-Mieras MM, de Mutsert G, van Amerongen G, van den Brand JM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. PLoS One. 2009; 4(5):e5538. Epub 2009 May 14.
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. [J Virol. 2006]
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
Stephenson I, Zambon MC, Rudin A, Colegate A, Podda A, Bugarini R, Del Giudice G, Minutello A, Bonnington S, Holmgren J, et al. J Virol. 2006 May; 80(10):4962-70.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Report of meeting on the development of influenza vaccines with broad spectrum a...
Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004.
Vaccine. 2005 Feb 18 ;23(13):1529-33.

PubMed
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-co...
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Am J Kidney Dis. 2005 Mar ;45(3):485-93.

PubMed
[Correction of forearm deformities in children with multiple cartilaginous osteo...
[Correction of forearm deformities in children with multiple cartilaginous osteochondromas].
Z Orthop Ihre Grenzgeb. 2005 Jan-Feb ;143(1):106-11.

PubMed
HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-...
HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses.
Breast Cancer Res Treat. 2005 Feb ;89(3):309-12.

PubMed
Metabolic and cardiorespiratory responses of tetraplegic subjects during treadmi...
Metabolic and cardiorespiratory responses of tetraplegic subjects during treadmill walking using neuromuscular electrical stimulation and partial body weight support.
Spinal Cord. 2005 Jul ;43(7):400-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information